A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
Thomas Jefferson University
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
Barbara Ann Karmanos Cancer Institute
Northwestern University
Northwestern University
OHSU Knight Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center